From cool automobile museums to art, railway, chocolate and history. These museums in Orlando will educate and entertain all ...

A class of University of Texas astronomy students has discovered that nearby dwarf galaxy Segue-1 seems to host a ...

Astronomers from the International Centre of Radio Astronomy Research (ICRAR) have released an incredible image of the Milky Way shining in low-frequency radio light, revealing a spectacular realm ...

A 101-year-old Leicestershire woman says staying active makes her feel "on top of the world". According to Blaby council, Eileen has "hardly" missed an exercise class in the last five years Proving ...

JKBOSE has released the Class 10th Annual/Regular exam date-sheet for the October–November 2025 session, with exams starting on November 3. Approximately 95,000 students from Kashmir Division, Jammu’s ...

After receiving his degree in Journalism & Media Communications from CSU in 2019, Erik began building his career in online media, and found his dream job when he joined Game Rant as a staff writer.

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A ...

The Kansas Jayhawks now own one of the best recruiting classes in the country after a monumental week on the recruiting trail by head coach Bill Self and the Kansas coaching staff. In the span of ...

On October 14, 1947, Captain Chuck Yeager piloted the Bell X-1 aircraft, "Glamorous Glennis," achieving a speed of Mach 1.06. This flight disproved prevailing expert warnings that exceeding Mach 1 ...

Diego is a writer and editor with over six years of experience covering games. He's mainly focused on guides, but he's done reviews, features, news, and everything in between. A fan of all genres, you ...

Students at i3 Academy got a closer look at the stars Wednesday as the U.S. Space and Rocket Center brought its mobile ...

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Series ...